Collie Gavin W, Michaelides Iacovos N, Embrey Kevin, Stubbs Christopher J, Börjesson Ulf, Dale Ian L, Snijder Arjan, Barlind Louise, Song Kun, Khurana Puneet, Phillips Christopher, Storer R Ian
Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.
Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
ACS Med Chem Lett. 2020 Dec 8;12(1):162-167. doi: 10.1021/acsmedchemlett.0c00392. eCollection 2021 Jan 14.
We report here a fragment screen directed toward the c-MET kinase from which we discovered a series of inhibitors able to bind to a rare conformation of the protein in which the P-loop adopts a collapsed, or folded, arrangement. Preliminary SAR exploration led to an inhibitor () with nanomolar biochemical activity against c-MET and promising cell activity and kinase selectivity. These findings increase our structural understanding of the folded P-loop conformation of c-MET and provide a sound structural and chemical basis for further investigation of this underexplored yet potentially therapeutically exploitable conformational state.
我们在此报告了一项针对c-MET激酶的片段筛选,从中发现了一系列能够结合该蛋白罕见构象的抑制剂,在这种构象中,P环呈塌陷或折叠排列。初步的构效关系探索产生了一种对c-MET具有纳摩尔生化活性、具有良好细胞活性和激酶选择性的抑制剂()。这些发现加深了我们对c-MET折叠P环构象的结构理解,并为进一步研究这种尚未充分探索但可能具有治疗开发潜力的构象状态提供了坚实的结构和化学基础。